KNSA Kiniksa Pharmaceuticals International, plc
Nasdaq · SEC CIK 1730430 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $61.90M 29 sales by 8 insiders
- Filings on record
- 268 since 2021-07-01, latest 2026-09-03 16:49
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Patel Sanj K | COB, CEO, Dir | — | $39.43M |
| Paolini John F. | Chief MEDICAL Off | — | $8.00M |
| Ragosa Mark | CFO | — | $5.56M |
| Tessari Eben | Chief STRATEGY Off | — | $3.10M |
| Quart Barry D | Dir | — | $2.68M |
| Megna Michael R | CAO | — | $2.64M |
| Cole G Bradley | Dir | — | $299.1K |
| Moat Ross | COO | — | $194.5K |
| McCain Tracey L | Dir | — | — |
| Levy Richard S | Dir | — | — |
Transactions 443
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-09 | 2025-04-07 | KNSA | Megna Michael R | CAO | M - OptEx | — | +3,933 | 34.2K | +13% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $21.77 | -5,321 | 94.5K | -5% | -$115.8K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +12.7K | 90.6K | +16% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $21.77 | -991 | 56.2K | -2% | -$21.6K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | — | +3,374 | 54.9K | +7% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $21.77 | -984 | 26.4K | -4% | -$21.4K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +3,352 | 25.2K | +15% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Megna Michael R | CAO | F - Tax | $21.77 | -2,084 | 31.3K | -6% | -$45.4K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Megna Michael R | CAO | M - OptEx | — | +4,920 | 32.4K | +18% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Ragosa Mark | CFO | F - Tax | $21.77 | -1,617 | 25.9K | -6% | -$35.2K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +3,342 | 25.1K | +15% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Tessari Eben | COO | M - OptEx | — | +3,519 | 79.7K | +5% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Tessari Eben | COO | F - Tax | $21.77 | -1,034 | 81.0K | -1% | -$22.5K |
| D | 2025-03-24 | 2025-03-20 | KNSA | Ragosa Mark | CFO | M - OptEx | $12.97 | +15.9K | 39.3K | +68% | +$206.8K |
| D | 2025-03-24 | 2025-03-20 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $23.11 | -15.9K | 23.4K | -41% | -$368.5K |
| DM | 2025-03-19 | 2025-03-16+ | KNSA | Ragosa Mark | CFO | M - OptEx | $12.97 | +21.2K | 34.8K | +156% | +$275.2K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Ragosa Mark | CFO | F - Tax | $22.61 | -448 | 23.4K | -2% | -$10.1K |
| DM | 2025-03-19 | 2025-03-17+ | KNSA | Ragosa Mark | CFO | S - Sale+OE | $23.10 | -20.3K | 23.4K | -47% | -$469.9K |
| D | 2025-03-19 | 2025-01-15 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $16.00 | +1,118 | 22.9K | +5% | +$17.9K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $22.61 | -292 | 23.6K | -1% | -$6,602 |
| D | 2025-03-19 | 2025-03-16 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +994 | 23.8K | +4% | — |
| D | 2025-03-19 | 2025-03-16 | KNSA | Tessari Eben | COO | F - Tax | $22.61 | -577 | 78.0K | -0.7% | -$13.0K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Tessari Eben | COO | M - OptEx | — | +1,964 | 78.5K | +3% | — |
| D | 2025-03-19 | 2025-03-16 | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $22.61 | -2,004 | 84.1K | -2% | -$45.3K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,569 | 86.1K | +8% | — |
| D | 2025-03-19 | 2025-01-15 | KNSA | Megna Michael R | CAO | A - Grant | $16.00 | +469 | 27.0K | +2% | +$7,504 |
| D | 2025-03-19 | 2025-03-16 | KNSA | Megna Michael R | CAO | M - OptEx | — | +774 | 27.8K | +3% | — |
| D | 2025-03-19 | 2025-03-16 | KNSA | Megna Michael R | CAO | F - Tax | $22.61 | -328 | 27.4K | -1% | -$7,416 |
| D | 2025-03-19 | 2025-03-16 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | — | +1,725 | 53.8K | +3% | — |
| D | 2025-03-19 | 2025-03-16 | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $22.61 | -507 | 53.3K | -0.9% | -$11.5K |
| D | 2025-03-14 | 2025-03-12 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $22.25 | -36.4K | 23.0K | -61% | -$809.3K |
| D | 2025-03-14 | 2025-03-12 | KNSA | Ragosa Mark | CFO | M - OptEx | $11.97 | +36.4K | 59.3K | +158% | +$435.4K |
| D | 2025-03-14 | 2025-03-12 | KNSA | Megna Michael R | CAO | M - OptEx | $11.10 | +9,051 | 35.6K | +34% | +$100.5K |
| D | 2025-03-14 | 2025-03-12 | KNSA | Megna Michael R | CAO | S - Sale+OE | $22.45 | -9,051 | 26.5K | -25% | -$203.2K |
| D | 2025-03-12 | 2025-03-10 | KNSA | Tessari Eben | COO | S - Sale+OE | $21.06 | -12.4K | 76.6K | -14% | -$261.3K |
| D | 2025-03-12 | 2025-03-10 | KNSA | Tessari Eben | COO | M - OptEx | $3.80 | +7,000 | 89.0K | +9% | +$26.6K |
| D | 2025-02-12 | 2025-02-10 | KNSA | Tessari Eben | COO | M - OptEx | $3.80 | +7,000 | 96.0K | +8% | +$26.6K |
| D | 2025-02-12 | 2025-02-10 | KNSA | Tessari Eben | COO | S - Sale+OE | $19.57 | -14.0K | 82.0K | -15% | -$274.0K |
| DM | 2025-01-15 | 2025-01-13 | KNSA | Tessari Eben | COO | S - Sale+OE | $18.24 | -14.0K | 90.7K | -13% | -$255.4K |
| D | 2025-01-15 | 2025-01-13 | KNSA | Tessari Eben | COO | M - OptEx | $3.80 | +7,000 | 103.0K | +7% | +$26.6K |
| D | 2024-12-18 | 2024-12-16 | KNSA | Tessari Eben | COO | M - OptEx | $1.59 | +16.0K | 119.0K | +16% | +$25.5K |
| D | 2024-12-18 | 2024-12-16 | KNSA | Tessari Eben | COO | S - Sale+OE | $20.44 | -23.0K | 96.0K | -19% | -$470.5K |
| DM | 2024-12-10 | 2024-12-06+ | KNSA | Ragosa Mark | CFO | M - OptEx | $11.06 | +21.3K | 41.8K | +103% | +$235.2K |
| DM | 2024-12-10 | 2024-12-06+ | KNSA | Ragosa Mark | CFO | S - Sale+OE | $21.34 | -27.8K | 23.0K | -55% | -$594.0K |
| DM | 2024-12-05 | 2024-12-03+ | KNSA | Ragosa Mark | CFO | M - OptEx | $10.76 | +15.1K | 24.1K | +169% | +$162.6K |
| DM | 2024-12-05 | 2024-12-03+ | KNSA | Ragosa Mark | CFO | S - Sale+OE | $21.37 | -15.1K | 23.0K | -40% | -$323.0K |
| DM | 2024-12-02 | 2024-11-27+ | KNSA | Megna Michael R | CAO | S - Sale+OE | $22.45 | -8,646 | 26.5K | -25% | -$194.1K |
| DM | 2024-12-02 | 2024-11-27+ | KNSA | Megna Michael R | CAO | M - OptEx | $11.10 | +8,646 | 35.2K | +33% | +$96.0K |
| D | 2024-11-20 | 2024-11-18 | KNSA | Tessari Eben | COO | S - Sale+OE | $21.04 | -17.0K | 103.0K | -14% | -$357.7K |
| D | 2024-11-20 | 2024-11-18 | KNSA | Tessari Eben | COO | M - OptEx | $1.59 | +10.0K | 120.0K | +9% | +$15.9K |
| D | 2024-11-12 | 2024-11-07 | KNSA | Levy Richard S | Dir | M - OptEx | — | +1,303 | 14.2K | +10% | — |
| D | 2024-11-08 | 2024-11-06 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +89.6K | 169.1K | +113% | +$142.4K |
| D | 2024-11-08 | 2024-11-06 | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $23.00 | -89.6K | 79.6K | -53% | -$2.06M |
| D | 2024-10-17 | 2024-10-15 | KNSA | Tessari Eben | COO | S - Sale+OE | $26.87 | -17.0K | 110.0K | -13% | -$456.8K |
| D | 2024-10-17 | 2024-10-15 | KNSA | Tessari Eben | COO | M - OptEx | $1.59 | +10.0K | 127.0K | +9% | +$15.9K |
| D | 2024-10-08 | 2024-10-04 | KNSA | Megna Michael R | CAO | M - OptEx | — | +175 | 26.6K | +0.7% | — |
| D | 2024-10-08 | 2024-10-04 | KNSA | Megna Michael R | CAO | F - Tax | $24.48 | -82 | 26.5K | -0.3% | -$2,007 |
| DMI | 2024-10-08 | 2024-10-04 | KNSA | Baker Brothers Life Sciences LP | Dir | A - Grant | $0.00 | +9,460 | 2.73M | +0.3% | $0 |
| D | 2024-09-25 | 2024-09-23 | KNSA | Tessari Eben | COO | S - Sale+OE | $24.99 | -17.5K | 117.0K | -13% | -$437.3K |
| D | 2024-09-25 | 2024-09-23 | KNSA | Tessari Eben | COO | M - OptEx | $1.59 | +10.0K | 134.5K | +8% | +$15.9K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +23.0K | 82.7K | +39% | — |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $26.74 | -11.1K | 76.2K | -13% | -$298.0K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $26.74 | -2,829 | 52.0K | -5% | -$75.6K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $1.88 | +66.5K | 112.3K | +146% | +$124.8K |
| DM | 2024-09-04 | 2024-09-03 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $26.12 | -60.7K | 52.0K | -54% | -$1.58M |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Ragosa Mark | CFO | F - Tax | $26.74 | -3,216 | 23.0K | -12% | -$86.0K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Ragosa Mark | CFO | M - OptEx | — | +6,305 | 23.9K | +36% | — |
| D | 2024-09-04 | 2024-07-15 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $15.65 | +211 | 18.4K | +1% | +$3,302 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $10.95 | +73.6K | 22.5K | New | +$805.9K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $26.74 | -1,738 | 21.7K | -7% | -$46.5K |
| DM | 2024-09-04 | 2024-09-03 | KNSA | Moat Ross | Chief COMMERCIAL Off | S - Sale+OE | $26.12 | -68.5K | 22.9K | -75% | -$1.79M |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Tessari Eben | COO | F - Tax | $26.74 | -1,899 | 123.1K | -2% | -$50.8K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | +6,463 | 125.1K | +5% | $0 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Megna Michael R | CAO | M - OptEx | — | +7,265 | 26.8K | +37% | — |
| D | 2024-09-04 | 2024-07-15 | KNSA | Megna Michael R | CAO | A - Grant | $15.65 | +480 | 22.3K | +2% | +$7,512 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Megna Michael R | CAO | F - Tax | $26.74 | -3,084 | 26.0K | -11% | -$82.5K |
| D | 2024-08-29 | 2024-08-27 | KNSA | Tessari Eben | COO | S - Sale+OE | $26.91 | -17.5K | 119.9K | -13% | -$470.9K |
| D | 2024-08-29 | 2024-08-27 | KNSA | Tessari Eben | COO | M - OptEx | $1.59 | +10.0K | 137.4K | +8% | +$15.9K |
| DM | 2024-07-25 | 2024-07-23 | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $25.65 | -136.1K | 126.1K | -52% | -$3.49M |
| D | 2024-07-25 | 2024-07-23 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +136.1K | 199.1K | +216% | +$216.4K |
| D | 2024-07-25 | 2024-07-23 | KNSA | Ragosa Mark | CFO | M - OptEx | $11.10 | +24.2K | 43.5K | +126% | +$269.2K |
| D | 2024-07-25 | 2024-07-23 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $24.79 | -24.2K | 19.3K | -56% | -$601.1K |
| DM | 2024-07-25 | 2024-07-23 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $26.32 | -22.0K | 64.3K | -26% | -$579.0K |
| D | 2024-07-25 | 2024-07-23 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $1.86 | +22.0K | 69.8K | +46% | +$40.9K |
| D | 2024-06-07 | 2024-06-06 | KNSA | Quart Barry D | Dir | M - OptEx | — | +4,373 | 9,373 | +87% | — |
| DMI | 2024-06-07 | 2024-06-05 | KNSA | BAKER JULIAN | Dir | A - Grant | $0.00 | +12.7K | 124.1K | +11% | $0 |
| D | 2024-06-07 | 2024-06-06 | KNSA | McCain Tracey L | Dir | M - OptEx | — | +4,373 | 9,373 | +87% | — |
| D | 2024-06-07 | 2024-06-06 | KNSA | Popovits Kimberly J | Dir | M - OptEx | — | +4,373 | 9,373 | +87% | — |
| D | 2024-06-07 | 2024-06-06 | KNSA | Cole G Bradley | Dir | M - OptEx | — | +4,373 | 9,373 | +87% | — |
| D | 2024-06-07 | 2024-06-06 | KNSA | Levy Richard S | Dir | M - OptEx | — | +4,373 | 12.9K | +51% | — |
| D | 2024-06-07 | 2024-06-06 | KNSA | Malley Thomas | Dir | M - OptEx | — | +4,373 | 9,373 | +87% | — |
| D | 2024-05-07 | 2024-05-03 | KNSA | Levy Richard S | Dir | M - OptEx | — | +747 | 8,524 | +10% | — |
| D | 2024-04-30 | 2024-04-26 | KNSA | Ragosa Mark | CFO | F - Tax | $17.88 | -509 | 19.3K | -3% | -$9,101 |
| D | 2024-04-30 | 2024-04-26 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +991 | 19.8K | +5% | — |
| D | 2024-04-08 | 2024-04-08 | KNSA | Tessari Eben | COO | M - OptEx | — | +2,726 | 126.8K | +2% | — |
| D | 2024-04-08 | 2024-04-08 | KNSA | Tessari Eben | COO | F - Tax | $17.90 | -801 | 126.0K | -0.6% | -$14.3K |
| D | 2024-04-08 | 2024-04-08 | KNSA | Ragosa Mark | CFO | F - Tax | $17.90 | -791 | 18.8K | -4% | -$14.2K |
| D | 2024-04-08 | 2024-04-08 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +2,694 | 19.6K | +16% | — |
| D | 2024-04-08 | 2024-04-08 | KNSA | Megna Michael R | CAO | M - OptEx | — | +3,932 | 23.0K | +21% | — |
| D | 2024-04-08 | 2024-04-08 | KNSA | Megna Michael R | CAO | F - Tax | $17.90 | -1,666 | 21.3K | -7% | -$29.8K |
Purchase Sale Sale after option exercise All abbreviations